Biofil Chemicals (India) Performance
| BIOFILCHEM | 62.77 0.86 1.39% |
Biofil Chemicals has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.87, which signifies possible diversification benefits within a given portfolio. Biofil Chemicals returns are very sensitive to returns on the market. As the market goes up or down, Biofil Chemicals is expected to follow. Biofil Chemicals Pha right now shows a risk of 4.24%. Please confirm Biofil Chemicals Pha sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to decide if Biofil Chemicals Pha will be following its price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Biofil Chemicals Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical indicators, Biofil Chemicals is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
1 | Biofil Chemicals Pharmaceuticals Receives Sell Rating Due to Weak Financials and Valuation - MarketsMojo | 10/18/2024 |
2 | Biofil Chem Standalone September 2024 Net Sales at Rs 2.41 crore, down 86.11 percent Y-o-Y - Moneycontrol | 11/21/2024 |
| Begin Period Cash Flow | 376 K |
Biofil |
Biofil Chemicals Relative Risk vs. Return Landscape
If you would invest 6,395 in Biofil Chemicals Pharmaceuticals on August 31, 2024 and sell it today you would lose (118.00) from holding Biofil Chemicals Pharmaceuticals or give up 1.85% of portfolio value over 90 days. Biofil Chemicals Pharmaceuticals is generating 0.0554% of daily returns and assumes 4.2437% volatility on return distribution over the 90 days horizon. Simply put, 37% of stocks are less volatile than Biofil, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Biofil Chemicals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biofil Chemicals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biofil Chemicals Pharmaceuticals, and traders can use it to determine the average amount a Biofil Chemicals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0131
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | BIOFILCHEM | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.24 actual daily | 37 63% of assets are more volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 1 99% of assets perform better |
Based on monthly moving average Biofil Chemicals is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biofil Chemicals by adding it to a well-diversified portfolio.
Biofil Chemicals Fundamentals Growth
Biofil Stock prices reflect investors' perceptions of the future prospects and financial health of Biofil Chemicals, and Biofil Chemicals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biofil Stock performance.
| Return On Equity | 0.04 | ||||
| Return On Asset | 0.0144 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 1.01 B | ||||
| Shares Outstanding | 16.27 M | ||||
| Price To Book | 5.48 X | ||||
| Price To Sales | 2.22 X | ||||
| Revenue | 400.35 M | ||||
| Gross Profit | 25.63 M | ||||
| EBITDA | 13.06 M | ||||
| Net Income | 7.09 M | ||||
| Cash And Equivalents | 260 K | ||||
| Total Debt | 4.39 M | ||||
| Book Value Per Share | 11.19 X | ||||
| Cash Flow From Operations | 23.94 M | ||||
| Earnings Per Share | 0.33 X | ||||
| Total Asset | 470.83 M | ||||
| Retained Earnings | (318.26 M) | ||||
About Biofil Chemicals Performance
By analyzing Biofil Chemicals' fundamental ratios, stakeholders can gain valuable insights into Biofil Chemicals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Biofil Chemicals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biofil Chemicals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Biofil Chemicals is entity of India. It is traded as Stock on NSE exchange.Things to note about Biofil Chemicals Pha performance evaluation
Checking the ongoing alerts about Biofil Chemicals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biofil Chemicals Pha help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biofil Chemicals Pha had very high historical volatility over the last 90 days | |
| Biofil Chemicals Pha is unlikely to experience financial distress in the next 2 years | |
| About 60.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Biofil Chem Standalone September 2024 Net Sales at Rs 2.41 crore, down 86.11 percent Y-o-Y - Moneycontrol |
- Analyzing Biofil Chemicals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biofil Chemicals' stock is overvalued or undervalued compared to its peers.
- Examining Biofil Chemicals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biofil Chemicals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biofil Chemicals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biofil Chemicals' stock. These opinions can provide insight into Biofil Chemicals' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Biofil Stock analysis
When running Biofil Chemicals' price analysis, check to measure Biofil Chemicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofil Chemicals is operating at the current time. Most of Biofil Chemicals' value examination focuses on studying past and present price action to predict the probability of Biofil Chemicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofil Chemicals' price. Additionally, you may evaluate how the addition of Biofil Chemicals to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |